PlainRecalls
FDA Devices Moderate Class II Terminated

Separation Technology Creamatocrit Plus, Catalog Number: 100-146

Reported: April 20, 2022 Initiated: March 16, 2022 #Z-0905-2022

Product Description

Separation Technology Creamatocrit Plus, Catalog Number: 100-146

Reason for Recall

The device was being marketed as an IVD without a 510(k). Therefore, performance characteristics of these breast milk analyzers have not been adequately validated. An erroneous result could lead to sub-optimal nutrition supplementation for patients (infants)

Details

Recalling Firm
Stanbio Laboratory, LP
Units Affected
50
Distribution
US Nationwide Distribution CA, TX, OK, SD, IL, NV, MO, FL, WA, KY, WI, PA, NC, GA, MD, MN
Location
Boerne, TX

Frequently Asked Questions

What product was recalled?
Separation Technology Creamatocrit Plus, Catalog Number: 100-146. Recalled by Stanbio Laboratory, LP. Units affected: 50.
Why was this product recalled?
The device was being marketed as an IVD without a 510(k). Therefore, performance characteristics of these breast milk analyzers have not been adequately validated. An erroneous result could lead to sub-optimal nutrition supplementation for patients (infants)
Which agency issued this recall?
This recall was issued by the FDA Devices on April 20, 2022. Severity: Moderate. Recall number: Z-0905-2022.